| Literature DB >> 15688076 |
Nigel Gregson1, Keiron Sparrowhawk, Josephine Mauskopf, John Paul.
Abstract
The pricing of medicines has become one of the most hotly debated topics of recent times, with the pharmaceutical industry seemingly being attacked from all quarters. From a company perspective, determining the price for each new product is more crucial than ever, given the present dearth of new drug introductions. But how are pricing strategies developed in practice? What is value-based pricing and how are financial models of return on investment constructed? What are the challenges faced in setting the price for a particular product, and how will scientific and environmental trends provide future pricing challenges or opportunities?Mesh：
Year: 2005 PMID： 15688076 DOI： 10.1038/nrd1633
Source DB: PubMed Journal: Nat Rev Drug Discov ISSN： 1474-1776 Impact factor: 84.694